BE
BetterLife Pharma Inc.
BETRF · OTC
$0.23 +3.70% (+$0.01)
1M +2.68%
Market Cap $52.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.14
39.1% downside
Current Price
$0.23
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BETRF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 32.84%
ROA 781.37%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.04x
Int. coverage -11.08x
Debt/Equity N/A
Stability
24 /100
Unstable Beta 0.22x
EPS volatility 40.67%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BETRF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ahmad Doroudian
Employees
7
Headquarters
Vancouver